Immunological Considerations in the Development of Vaccines

Overview

Journal Hum Vaccin Immunother

Specialty Allergy & Immunology

Date 2019 Aug 2

PMID 31368828

Citations 22

Authors

Sarah M Baker

James B McLachlan

Lisa A Morici

Affiliations

Soon will be listed here.

Abstract

is an opportunistic human pathogen capable of causing a wide range of potentially life-threatening infections. With multidrug-resistant infections on the rise, the need for a rationally-designed vaccine against this pathogen is critical. A number of vaccine platforms have shown promising results in pre-clinical studies, but no vaccine has successfully advanced to licensure. Growing evidence suggests that an effective vaccine may require Th17-type CD4 T cells to prevent infection. In this review, we summarize recent pre-clinical studies of vaccines, specifically focusing on those that induce Th17-type cellular immunity. We also highlight the importance of adjuvant selection and immunization route in vaccine design in order to target vaccine-induced immunity to infected tissues. Advances in cellular immunology and adjuvant biology may ultimately influence better vaccine platforms that can protect targeted human populations.

Citing Articles

Proteomic approach to identify host cell attachment proteins provides protective Pseudomonas aeruginosa vaccine antigen FtsZ.

Jurado-Martin I, Tomas-Cortazar J, Hou Y, Sainz-Mejias M, Mysior M, Sadones O NPJ Vaccines. 2024; 9(1):204.

PMID: 39468053 PMC: 11519640. DOI: 10.1038/s41541-024-00994-x.

A multiantigenic antibacterial nanovaccine utilizing hybrid membrane vesicles for combating Pseudomonas aeruginosa infections.

Peng X, Luo Y, Yang L, Yang Y, Yuan P, Chen X J Extracell Vesicles. 2024; 13(10):e12524.

PMID: 39400457 PMC: 11472236. DOI: 10.1002/jev2.12524.

Exploiting immunopotential PAPI-1 encoded type IVb major pilin targeting .

Arefian Jazi M, Hajikhani B, Goudarzi M, Ebrahimipour G Heliyon. 2024; 10(17):e36859.

PMID: 39281519 PMC: 11401190. DOI: 10.1016/j.heliyon.2024.e36859.

A computational approach to developing a multi-epitope vaccine for combating Pseudomonas aeruginosa-induced pneumonia and sepsis.

Roy S, Biswas M, Foyzur Raman M, Hasan R, Rahmann Z, Uddin P K M Brief Bioinform. 2024; 25(5).

PMID: 39133098 PMC: 11318047. DOI: 10.1093/bib/bbae401.

Development of a nano-emulsion based multivalent protein subunit vaccine against .

Howlader D, Mandal R, Lu T, Maiti S, Dietz Z, Das S Front Immunol. 2024; 15:1372349.

PMID: 38698863 PMC: 11063228. DOI: 10.3389/fimmu.2024.1372349.

References

Muranski P, Borman Z, Kerkar S, Klebanoff C, Ji Y, Sanchez-Perez L . Th17 cells are long lived and retain a stem cell-like molecular signature. Immunity. 2011; 35(6):972-85. PMC: 3246082. DOI: 10.1016/j.immuni.2011.09.019. View

Pier G . Promises and pitfalls of Pseudomonas aeruginosa lipopolysaccharide as a vaccine antigen. Carbohydr Res. 2003; 338(23):2549-56. DOI: 10.1016/s0008-6215(03)00312-4. View

Kolls J, Linden A . Interleukin-17 family members and inflammation. Immunity. 2004; 21(4):467-76. DOI: 10.1016/j.immuni.2004.08.018. View

Doring G, Pier G . Vaccines and immunotherapy against Pseudomonas aeruginosa. Vaccine. 2008; 26(8):1011-24. DOI: 10.1016/j.vaccine.2007.12.007. View

Manni M, Ding W, Stohl L, Granstein R . Muramyl dipeptide induces Th17 polarization through activation of endothelial cells. J Immunol. 2011; 186(6):3356-63. PMC: 3048901. DOI: 10.4049/jimmunol.1000847. View

Norton E, Lawson L, Mahdi Z, Freytag L, Clements J . The A subunit of Escherichia coli heat-labile enterotoxin functions as a mucosal adjuvant and promotes IgG2a, IgA, and Th17 responses to vaccine antigens. Infect Immun. 2012; 80(7):2426-35. PMC: 3416479. DOI: 10.1128/IAI.00181-12. View

Liu L, Johnson H, Cousens S, Perin J, Scott S, Lawn J . Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet. 2012; 379(9832):2151-61. DOI: 10.1016/S0140-6736(12)60560-1. View

Moser C, Jensen P, Kobayashi O, Hougen H, Song Z, Rygaard J . Improved outcome of chronic Pseudomonas aeruginosa lung infection is associated with induction of a Th1-dominated cytokine response. Clin Exp Immunol. 2002; 127(2):206-13. PMC: 1906339. DOI: 10.1046/j.1365-2249.2002.01731.x. View

Tribble D, Li P, Warkentien T, Lloyd B, Schnaubelt E, Ganesan A . Impact of Operational Theater on Combat and Noncombat Trauma-Related Infections. Mil Med. 2016; 181(10):1258-1268. PMC: 5123796. DOI: 10.7205/MILMED-D-15-00368. View

10.

Di Pasquale A, Preiss S, Da Silva F, Garcon N . Vaccine Adjuvants: from 1920 to 2015 and Beyond. Vaccines (Basel). 2015; 3(2):320-43. PMC: 4494348. DOI: 10.3390/vaccines3020320. View

11.

Tozuka M, Oka T, Jounai N, Egawa G, Ishii K, Kabashima K . Efficient antigen delivery to the draining lymph nodes is a key component in the immunogenic pathway of the intradermal vaccine. J Dermatol Sci. 2015; 82(1):38-45. DOI: 10.1016/j.jdermsci.2015.11.008. View

12.

Dubin P, McAllister F, Kolls J . Is cystic fibrosis a TH17 disease?. Inflamm Res. 2007; 56(6):221-7. DOI: 10.1007/s00011-007-6187-2. View

13.

Ye P, Garvey P, Zhang P, Nelson S, Bagby G, Summer W . Interleukin-17 and lung host defense against Klebsiella pneumoniae infection. Am J Respir Cell Mol Biol. 2001; 25(3):335-40. DOI: 10.1165/ajrcmb.25.3.4424. View

14.

Kamei A, Wu W, Traficante D, Koh A, van Rooijen N, Pier G . Collaboration between macrophages and vaccine-induced CD4+ T cells confers protection against lethal Pseudomonas aeruginosa pneumonia during neutropenia. J Infect Dis. 2012; 207(1):39-49. PMC: 3523801. DOI: 10.1093/infdis/jis657. View

15.

Alexander J, Fisher M . Vaccination for Pseudomonas aeruginosa. Am J Surg. 1970; 120(4):512. DOI: 10.1016/s0002-9610(70)80019-8. View

16.

Chen K, McAleer J, Lin Y, Paterson D, Zheng M, Alcorn J . Th17 cells mediate clade-specific, serotype-independent mucosal immunity. Immunity. 2011; 35(6):997-1009. PMC: 3406408. DOI: 10.1016/j.immuni.2011.10.018. View

17.

Zygmunt B, Rharbaoui F, Groebe L, Guzman C . Intranasal immunization promotes th17 immune responses. J Immunol. 2009; 183(11):6933-8. DOI: 10.4049/jimmunol.0901144. View

18.

Decraene V, Ghebrehewet S, Dardamissis E, Huyton R, Mortimer K, Wilkinson D . An outbreak of multidrug-resistant Pseudomonas aeruginosa in a burns service in the North of England: challenges of infection prevention and control in a complex setting. J Hosp Infect. 2018; 100(4):e239-e245. DOI: 10.1016/j.jhin.2018.07.012. View

19.

Blomberg B, Frasca D . Quantity, not quality, of antibody response decreased in the elderly. J Clin Invest. 2011; 121(8):2981-3. PMC: 3148749. DOI: 10.1172/JCI58406. View

20.

Hentzer M, Teitzel G, Balzer G, Heydorn A, Molin S, Givskov M . Alginate overproduction affects Pseudomonas aeruginosa biofilm structure and function. J Bacteriol. 2001; 183(18):5395-401. PMC: 95424. DOI: 10.1128/JB.183.18.5395-5401.2001. View